1. Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial. Issue 3 (March 2022) Authors: Fennell, Dean A; King, Amy; Mohammed, Seid; Greystoke, Alastair; Anthony, Sarah; Poile, Charlotte; Nusrat, Nada; Scotland, Molly; Bhundia, Vina; Branson, Amy; Brookes, Cassandra; Darlison, Liz; Dawson, Alan G; Gaba, Aarti; Hutka, Margaret; Morgan, Bruno; Bajaj, Amrita; Richards, Cathy; Wells-Jord... Journal: Lancet oncology Issue: Volume 23:Issue 3(2022) Page Start: 374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗